Overview

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Boehringer Ingelheim
Treatments:
Duloxetine Hydrochloride